Pharmaceutical API combination
Our expertise in API combination technology
Skyepharma stands at the forefront of API combination technologies, offering its expertise in the development and optimization of complex API combinations.
Our manufacturing facilities and expertise in advanced delivery OSD platforms enable us to offer tailored solutions for even the most complex API combinations. From fixed-dose combinations (FDCs) to novel therapeutic approaches, we excel in developing products that:
● Address unmet medical needs;
● Improve therapeutic outcomes through multi-modal action;
● Provide competitive differentiation in crowded markets.

Our API combination services
Identifying the potential of API combinations and assessing their viability from scientific, technical, and regulatory perspectives.
Conceptualization and Feasibility studies:
Leveraging advanced techniques, such as
co-crystallization, encapsulation, and multi-layer tablet technology, to achieve optimal API interaction and performance.
Formulation Development:
Creating robust analytical methodologies to characterize and monitor API interactions, ensuring consistency and quality throughout the product lifecycle.
Analytical method development:
Navigating the complexities of global regulatory requirements with precision and confidence, ensuring accelerated approval timelines.
Regulatory strategy and Submission support:
Challenges of API combination
The combination of APIs into a single formulation is a sophisticated process that requires precision, innovation, and deep scientific understanding. Skyepharma’s specialized approach addresses the challenges of:
Pharmacokinetic Compatibility:
Ensuring synergistic behavior between APIs to optimize therapeutic outcomes.
Chemical and Physical Stability:
Preventing interactions that may compromise formulation integrity or shelf life.
Targeted Delivery Systems:
Designing delivery mechanisms that enhance bioavailability and ensure precise release profiles for each active component.
Patient-Centric Formulations:
Creating combination products that improve compliance through reduced dosing frequency, minimized side effects, or simplified administration.